Venclyxto
venetoclax
Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation:
Revision: 18
Last updated:
MedicineHumanAuthorised
EMEA-002018-PIP02-16-M05 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Haematology-HemostaseologyOncology
PIP number: P/0148/2022
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Tablet for oral suspension
Powder for oral suspension
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Fanaptum
iloperidone
Schizophrenia
Date of refusal:
Last updated:
MedicineHumanRefused
Fanaptum
iloperidone
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
EMEA-000995-PIP01-10 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Psychiatry
PIP number: P/71/2011
Route(s) of administration: Intramuscular useOral use
Pharmaceutical form(s):
Suspension for injection
Tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman